ReviewBlood neoplasia2026
Predictors of sensitivity to immune therapies in classic Hodgkin lymphoma.
Mohamed Nazem Alibrahim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewBlood neoplasia2026
Mohamed Nazem Alibrahim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.